The Prognostic Role of RASSF1A Promoter Methylation in Breast Cancer: A Meta-Analysis of Published Data

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

High RASSF1A promoter methylation levels are predictive of poor prognosis in fine-needle aspirate washings of breast cancer lesions

(2010) Ana Teresa Martins et al.   BREAST CANCER RESEARCH AND TREATMENT

The prognostic value of RASSF1A promoter hypermethylation in non-small cell lung carcinoma: a systematic review and meta-analysis

(2010) Jun Wang et al.   CARCINOGENESIS

Determination of the methylation status of MGMT in different regions within glioblastoma multiforme

(2010) Mark G. Hamilton et al.   JOURNAL OF NEURO-ONCOLOGY

Gene-expression-based prognostic assays for breast cancer

(2010) Chungyeul Kim et al.   Nature Reviews Clinical Oncology

Methylation level of the RASSF1A promoter is an independent prognostic factor for clear-cell renal cell carcinoma

(2009) Y. Kawai et al.   ANNALS OF ONCOLOGY

RASSF1A hypermethylation in pretreatment serum DNA of neuroblastoma patients: a prognostic marker

(2009) A Misawa et al.   BRITISH JOURNAL OF CANCER

Prognostic significance of RASSF1A promoter methylation in operable breast cancer

(2009) Magdalini Kioulafa et al.   CLINICAL BIOCHEMISTRY

CpG Island Methylator Phenotype Predicts Progression of Malignant Melanoma

(2009) A. Tanemura et al.   CLINICAL CANCER RESEARCH

Aberrant methylation of RASSF1A is associated with poor survival in Tunisian breast cancer patients

(2009) Sondes Karray-Chouayekh et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

More Than Numbers: The Power of Graphs in Meta-Analysis

(2008) L. Bax et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Epigenetics in Cancer

(2008) Manel Esteller   NEW ENGLAND JOURNAL OF MEDICINE